Publicaciones en las que colabora con MARTIN ALDASORO CELAYA (26)

2020

  1. Relaxant and antiadrenergic effects of ranolazine in human saphenous vein

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 58, Núm. 2, pp. 277-285

2019

  1. Changes in chemokines and chemokine receptors expression in a mouse model of alzheimer’s disease

    International Journal of Biological Sciences, Vol. 15, Núm. 2, pp. 453-463

  2. Targeting early atherosclerosis: A focus on oxidative stress and inflammation

    Oxidative Medicine and Cellular Longevity, Vol. 2019

2018

  1. Chronic exercise impairs nitric oxide pathway in rabbit carotid and femoral arteries

    Journal of Physiology, Vol. 596, Núm. 18, pp. 4361-4374

  2. Nanoparticles in medicine: A focus on vascular oxidative stress

    Oxidative Medicine and Cellular Longevity, Vol. 2018

2017

  1. Bifidobacterium pseudocatenulatum CECT 7765 supplementation restores altered vascular function in an experimental model of obese mice

    International Journal of Medical Sciences, Vol. 14, Núm. 5, pp. 444-451

  2. Effects of photodynamic therapy in periodontal treatment: A randomized, controlled clinical trial

    Journal of Clinical Periodontology, Vol. 44, Núm. 9, pp. 915-925

  3. Material multimedia para aumentar el rendimiento académico de los trabajos en grupo

    In-Red 2017. III Congreso nacional de innovación educativa y docencia en red

  4. Multimedia material to increase the academic performance of group activities

    CONGRESO NACIONAL DE INNOVACION EDUCATIVA Y DOCENCIA EN RED (IN RED 2017)

  5. Neuronal effects of sugammadex in combination with rocuronium or vecuronium

    International Journal of Medical Sciences, Vol. 14, Núm. 3, pp. 224-230

2013

  1. Contractile responses of human thyroid arteries to vasopressin

    Life Sciences, Vol. 93, Núm. 15, pp. 525-529

  2. Endothelial dysfunction in morbid obesity

    Current Pharmaceutical Design, Vol. 19, Núm. 32, pp. 5718-5729

  3. Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures

    International Journal of Medical Sciences, Vol. 10, Núm. 10, pp. 1278-1285